Targeting CD28, CTLA-4 and PD-L1 Costimulation Differentially Controls Immune Synapses and Function of Human Regulatory and Conventional T-Cells | PLOS ONE
RCSB PDB - 7LM9: Crystal structure of SARS-CoV spike protein receptor-binding domain in complex with a cross-neutralizing antibody CV38-142 Fab isolated from COVID-19 patient
CTLA4 Gene - GeneCards | CTLA4 Protein | CTLA4 Antibody
Enfu Hui (@hui_enfu) / Twitter
Part:BBa K2295005 - parts.igem.org
![CTLA-4 in Regulatory T Cells for Cancer Immunotherapy[v1] | Preprints.org](https://www.preprints.org/img/dyn_abstract_figures/2021/02/1110d3c1d8222e2751944fb7b8b0194f/preprints-38751-GA.jpg "CTLA-4 in Regulatory T Cells for Cancer Immunotherapy[v1] | Preprints.org")
CTLA-4 in Regulatory T Cells for Cancer Immunotherapy[v1] | Preprints.org
JCI - Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
CTLA-4 - Wikiwand
Robert Plenge on Twitter: "Accordingly, interventions that interfere with co-stimulation of CD4+ T cells by APCs – CTLA4-Ig, which prevents the interaction between CD80/86 (on APCs) and CD28 (on T cells) –
Frontiers | TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer
CTLA-4 - Wikipedia
Cells | Free Full-Text | Exploring the Interactions of Oncolytic Viral Therapy and Immunotherapy of Anti-CTLA-4 for Malignant Melanoma Mice Model
What you need to know: Nobel Prize Winners 2018 – ARCHIVE
CTLA-4 - Wikipedia
File:CTLA-4 and PD-1 monoclonal antibody.jpg - Wikimedia Commons
Pembrolizumab – the miraculous drug – OncoBites
Immune checkpoint - Wikipedia
PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors | PNAS
CTLA-4 - Wikipedia
Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4 | Science
Definition of immune checkpoint inhibitor - NCI Dictionary of Cancer Terms - NCI
CTLA-4 discovery in dendritic cells - a new role in Cancer Immunotherapy? - Tebubio's blog
Role of CTLA4 in the Proliferation and Survival of Chronic Lymphocytic Leukemia | PLOS ONE
File:CTLA-4 and PD-1 receptor.jpg - Wikimedia Commons
